Yanchuang Capital logo

Yanchuang Capital

Asia, Beijing, China, Beijing

Description

Yanchuang Capital is a venture capital firm.

Investor Profile

Yanchuang Capital has made 8 investments, with 2 in the past 12 months and 13% as lead.

Stage Focus

  • Series B (38%)
  • Series C (25%)
  • Series D (13%)
  • Series A (13%)
  • Seed (13%)

Country Focus

  • China (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Care
  • Therapeutics
  • Manufacturing
  • Medical
  • Aerospace
  • Air Transportation
  • Industrial
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yanchuang Capital frequently co-invest with?

Boquan Capital
Asia, Shanghai, China, Hongkou
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Tao Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
SDIC Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 2
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 2
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1

Which angels does Yanchuang Capital often collaborate with?

Adrian Cheng
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by Yanchuang Capital?

Volant Aerotech

Minhang, Shanghai, China

Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL.

AerospaceAir TransportationIndustrialManufacturing
Series BDec 30, 2024
Volant Aerotech

Minhang, Shanghai, China

Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL.

AerospaceAir TransportationIndustrialManufacturing
Series AAug 19, 2024
Avistone Pharmaceuticals

Beijing, Beijing, China

Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

BiotechnologyOncology
Series BDec 28, 2023
Amount Raised: $140,686,550
Hongtu Semiconductor Technology

Beijing, Beijing, China

Hongtu Semiconductor Technology focuses on the CMOS image sensor chip design platform for producing CIS image sensors.

ManufacturingSemiconductorSensor
SeedAug 2, 2023
Amount Raised: $13,905,885
TenNor Therapeutics

Westfield, New Jersey, United States

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BiotechnologyMedicalTherapeutics
Series DMar 30, 2022
Amount Raised: $41,589,867
Immune-Onc Therapeutics

Palo Alto, California, United States

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

BiopharmaBiotechnologyHealth CareMedicalOncologyTherapeutics
Series BMar 30, 2021
Amount Raised: $73,000,000
EpimAb Biotherapeutics

Shanghai, Shanghai, China

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series CMar 22, 2021
Amount Raised: $120,000,000
Ark Biosciences

Shanghai, Shanghai, China

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CJan 22, 2021
Amount Raised: $86,000